INVOZONE LIMITED

Company number 14501664 ·

Dissolved

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

INVOZONE LIMITED - Analysis Report

Company Number: 14501664

Analysis Date: 2025-07-29 12:34 UTC

  1. Credit Opinion: DECLINE. INVOZONE LIMITED shows a negative net asset position as at 30 November 2024, with net current liabilities of £405 and total net liabilities of the same amount, deteriorating from a small positive net asset position the prior year. The company is a micro-entity with no employees, limited financial scale, and appears to be in early stages given incorporation in late 2022. The worsening working capital and net asset deficit indicate impaired ability to meet short-term obligations. Without evidence of profitability, cash generation, or external support, the risk of default is elevated.

  2. Financial Strength: The balance sheet is weak. Current liabilities (£605) exceed current assets (£200), resulting in a negative working capital of £405. Total net assets are negative £405, indicating liabilities exceed assets. The company has not reported any fixed assets or long-term investments. The shareholder funds are negative, reflecting accumulated losses or capital withdrawals. The financial trajectory from 2023 to 2024 shows deterioration in liquidity and net worth.

  3. Cash Flow Assessment: With minimal current assets and significant current liabilities, liquidity is strained. There is no information on cash or cash equivalents specifically, but the low current asset balance implies limited cash reserves. The absence of employees suggests minimal operating activities or capitalization on human resources. The company likely relies on external financing or shareholder advances to fund operations. Without positive cash flow or working capital, debt servicing capability is questionable.

  4. Monitoring Points:

  • Monitor subsequent filings for improvement in net assets and working capital.
  • Watch for any external financing or shareholder injections improving liquidity.
  • Review trading performance updates to assess revenue generation and profitability.
  • Track director appointments or changes, as management quality impacts recovery prospects.
  • Observe any overdue filings or signs of distress such as late payments or defaults.

Perspective: Business Credit Analyst · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.